These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8743787)

  • 1. [The antibacterial and immunocorrective action of ozone therapy in peritonitis].
    Vasil'ev IT; Markov IN; Mumladze RB; Belopol'skiĭ AA; Vasina TA
    Vestn Khir Im I I Grek; 1995; 154(3):56-60. PubMed ID: 8743787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ozone therapy of diffuse peritonitis in the early postoperative period].
    Kudriavtsev EP; Miroshin SI; Semenov SV; Snigorenko AS; Sidorovich IA
    Khirurgiia (Mosk); 1997; (3):36-41. PubMed ID: 9235377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of peritonitis using ozone and hydropressive technology].
    Bulynin VI; Glukhov AA
    Khirurgiia (Mosk); 1999; (7):9-11. PubMed ID: 10459177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial therapy of purulent peritonitis: a prospective randomized study on the effects of antibiotics and taurolin, a new chemotherapeutic and antiendotoxic agent (author's transl)].
    Linder MM; Ott W; Wesch G
    Chir Forum Exp Klin Forsch; 1980; ():67-71. PubMed ID: 7389482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The method of parietal-cavitary sanitation of intestines in complex treatment of acute diffuse peritonitis].
    Glukhov AA; Zhdanov AI; Andreev AA
    Vestn Khir Im I I Grek; 2004; 163(2):41-5. PubMed ID: 15199769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of combined and local cytokine- and ozone therapy on the indices of lipid peroxidation, endogenous intoxication and ferroproteins in diffuse peritonitis].
    Gadzhiev ND; Nasirov MIa; Sushkov SV; Klimova EM
    Vestn Khir Im I I Grek; 2014; 173(2):38-41. PubMed ID: 25055532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibacterial and immunocorrective therapy of diffuse purulent peritonitis].
    Zaĭtsev VT; Krivoruchko IA; Gusak IV; Klimova EM; Romanova LD; Boĭko VV; Lagoda AE
    Klin Khir (1962); 1992; (4):1-4. PubMed ID: 1630080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complex program of detoxication measures in terminal peritonitis using ozone and hydropressive technologies].
    Glukhov AA; Shapovalova NV
    Anesteziol Reanimatol; 1998; (6):56-8. PubMed ID: 10050339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of the causative agent of infection for therapy of purulent peritonitis].
    Wittmann DH; Teichmann W; Frommelt L
    Chirurg; 1985 Jun; 56(6):363-70. PubMed ID: 3896692
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of diffuse peritonitis].
    Blum E
    Z Allgemeinmed; 1973 Feb; 49(4):160-2. PubMed ID: 4701306
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of experimental infectious peritonitis].
    Fokin AA
    Tr Inst Im Pastera; 1982; 58():122-5. PubMed ID: 6196879
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sodium hypochlorite in the treatment of suppurative peritonitis].
    Petrosian EA
    Vestn Khir Im I I Grek; 1993; 150(5-6):18-21. PubMed ID: 8091571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of the preclinical toxicological study of antibacterial agents].
    Gus'kova TA
    Farmakol Toksikol; 1985; 48(3):119-22. PubMed ID: 3896843
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
    Tuncer I; Topcu N; Durmus A; Turkdogan MK
    Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-infection action of synthetic glycopeptides in an experiment on mice].
    Nikitina LE; Fridman EA; Noskov FS
    Tr Inst Im Pastera; 1982; 58():62-4. PubMed ID: 7187555
    [No Abstract]   [Full Text] [Related]  

  • 16. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.
    Terg R; Fassio E; Guevara M; Cartier M; Longo C; Lucero R; Landeira C; Romero G; Dominguez N; Muñoz A; Levi D; Miguez C; Abecasis R
    J Hepatol; 2008 May; 48(5):774-9. PubMed ID: 18316137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental-clinical grounds of the application of immobilized forms of sodium hypochlorite in treatment of diffuse peritonitis].
    Sukovatykh BS; Blinkov IuIu; Eshtokin SA; Frolova OG
    Vestn Khir Im I I Grek; 2008; 167(6):44-7. PubMed ID: 19241815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
    Goffin E; Pouthier D; Vandercam B; Gigi J; van Ypersele de Strihou C
    Clin Nephrol; 1997 Dec; 48(6):391-2. PubMed ID: 9438101
    [No Abstract]   [Full Text] [Related]  

  • 19. [A prospective study on short period antibiotic treatment of hepatic failure complicated with spontaneous bacterial peritonitis].
    Li HW; Zhao P; Wang HF; Ji W; He WP; Du N; Xia J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Jun; 18(2):179-80. PubMed ID: 15340512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimization of empirical antibacterial therapy of diffuse purulent peritonitis during the stage of multiple organ failure].
    Efimenko NA; Kemerov CV
    Voen Med Zh; 2004 Feb; 325(2):33-9, 96. PubMed ID: 15101292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.